Yanaga F, Asselin J, Schieven G L, Watson S P
University Department of Pharmacology, Oxford, UK.
FEBS Lett. 1995 Jul 17;368(2):377-80. doi: 10.1016/0014-5793(95)00670-5.
The sulphydryl reagent phenylarsine oxide (PAO) (1 microM) inhibited completely formation of inositol phosphates in human platelets induced by collagen or by cross-linking of the platelet low affinity Fc receptor, F c gamma RIIA, but did not alter the response to the G protein receptor agonist thrombin. PAO also inhibited completely tyrosine phosphorylation of PLC gamma 2 in collagen and Fc gamma RIIA-stimulated cells, although tyrosine phosphorylation of other proteins including the tyrosine kinase syk was relatively unaffected. PAO (1 microM) also inhibited completely tyrosine phosphorylation of PLC gamma 1 induced by platelet derived growth factor (PDGF) in NIH-3T3 fibroblasts but only partially reduced phosphorylation of the PDGF receptor. These results provide further evidence that collagen and Fc gamma RIIA cross-linking activate platelets through a pathway distinct from that used by thrombin and suggest that PAO may be a selective inhibitor of PLC gamma relative to PLC beta isozymes.
巯基试剂苯胂氧化物(PAO)(1微摩尔)完全抑制了胶原蛋白或血小板低亲和力Fc受体FcγRIIA交联诱导的人血小板中肌醇磷酸的形成,但不改变对G蛋白受体激动剂凝血酶的反应。PAO还完全抑制了胶原蛋白和FcγRIIA刺激的细胞中PLCγ2的酪氨酸磷酸化,尽管包括酪氨酸激酶syk在内的其他蛋白质的酪氨酸磷酸化相对未受影响。PAO(1微摩尔)也完全抑制了血小板衍生生长因子(PDGF)在NIH-3T3成纤维细胞中诱导的PLCγ1的酪氨酸磷酸化,但仅部分降低了PDGF受体的磷酸化。这些结果进一步证明,胶原蛋白和FcγRIIA交联通过一条不同于凝血酶的途径激活血小板,并表明相对于PLCβ同工酶,PAO可能是PLCγ的选择性抑制剂。